Redhill Biopharma
RDHL
£1.11
Share price
-9.20%
Change (1 day)
-85.53%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Total debt
Total debt on the balance sheet as of December 2024 : £0.26 Million
According to Redhill Biopharma's latest financial reports the company's total debt is £0.26 Million. A company’s total debt is the sum of all current and non-current debts.
Redhill Biopharma - Total debt on balance sheet (from 2018 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | £0.92 M | -99.09% |
| 2022-12-31 | £0.10 B | 55.89% |
| 2021-12-31 | £65.05 M | 2.04% |
| 2020-12-31 | £63.75 M | 2091.42% |
| 2019-12-31 | £2.9 M | |
| 2018-12-31 | N/A |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | £17.05 B | 6,396,107.87% | 🇫🇷 France |
 Merck MRK | £26.09 B | 9,787,540.45% | 🇺🇸 USA |
 GlaxoSmithKline GSK | £17.83 B | 6,689,731.46% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | £1.46 M | 447.75% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | £12.68 B | 4,758,046.07% | 🇮🇱 Israel |